Sign In
Buy CTLT
$63.49
+0 (+0%)
At Close: Mar 14, 2025
3 Reasons to Add Catalent (CTLT) Stock to Your Portfolio
04:42pm, Monday, 18'th Oct 2021
Investors continue to be optimistic about Catalent (CTLT) owing to its slew of strategic deals and product launches.
Catalent: Biologic-Driven Organic Growth
04:52pm, Thursday, 07'th Oct 2021
Catalent has enjoyed significant revenue growth over the pandemic, with its Biologic segment showing a massive 89% net revenue increase over the past 12 months.
7 Healthcare Stocks to Add to Your Portfolio
02:21pm, Wednesday, 06'th Oct 2021
Healthcare stocks could take over from energy stocks as top dog during this defensive cycle as yields move higher and tech stocks lose value. The post 7 Healthcare Stocks to Add to Your Portfolio appe
MedTech Thrives on M&A Frenzy: 3 Stocks to Focus on
11:08am, Thursday, 30'th Sep 2021
MedTech stocks like Boston Scientific (BSX), Catalent (CTLT) and Baxter (BAX) are likely to solidify businesses on the back of impressive M&As.
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2030
06:49pm, Thursday, 23'rd Sep 2021
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics;
Catalent Announces Launch of Private Offering of $450 Million of Senior Unsecured Notes Due 2030
07:49am, Thursday, 23'rd Sep 2021
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics;
Here's Why You Should Retain Catalent (CTLT) Stock For Now
10:40am, Thursday, 16'th Sep 2021
Investors continue to be optimistic about Catalent (CTLT) owing to its slew of strategic deals and product launches.
Catalent, Inc. to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
07:45am, Tuesday, 07'th Sep 2021
SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT), the leading global provider of development sciences and manufacturing platforms for medicines, including biotherapeutics; cell and gene th
Recap: Catalent Q4 Earnings
09:37am, Wednesday, 01'st Sep 2021
(Catalent:CTLT) stock rose by 0.1% after the company reported their Q4 earnings results on Monday, August 30, 2021 at 10:50 PM. Here's what investors need to know about the announcement.
Catalent - Missing The Catalyst After The Pandemic
10:53am, Tuesday, 31'st Aug 2021
Catalent has been doing extremely well in recent years on the back of organic growth, bolt-on deals, and the pandemic. I like the track record of the business and while the business has been doing wel
Catalent, Inc.'s (CTLT) CEO John Chiminski on Q4 2021 Results - Earnings Call Transcript
02:51pm, Monday, 30'th Aug 2021
Catalent, Inc.'s (CTLT) CEO John Chiminski on Q4 2021 Results - Earnings Call Transcript
Catalent's (CTLT) Q4 Earnings Top Estimates, Margins Rise
12:10pm, Monday, 30'th Aug 2021
Catalent's (CTLT) robust performance across the majority of its segments drives its fourth-quarter fiscal 2021 top line.
Catalent (CTLT) Q4 Earnings and Revenues Surpass Estimates
09:54am, Monday, 30'th Aug 2021
Catalent (CTLT) delivered earnings and revenue surprises of 11.54% and 5.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Catalent Makes Strategic Move For Consumer Health Business With Bettera Deal
08:44am, Monday, 30'th Aug 2021
Catalent Inc (NYSE: CTLT) has reported Q4 sales of $1.19 billion, +25% Y/Y as reported, or 22% in constant currency, edging out analysts' average expectation of $1.14 billion. Adjusted EPS of $1.16
Catalent to acquire gummy maker Bettera from Highlander Partners for $1 billion in cash
07:09am, Monday, 30'th Aug 2021
Catalent Inc. CTLT, -0.35% said Monday it has reached an agreement to acquire Bettera Holdings LLC, a maker of gummy, soft chew and lozenges as nutritional supplements, from Highlander Partners LP for
